Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120889773 | 12088977 | 3 | F | 200412 | 20160708 | 20160218 | 20160712 | EXP | PHJP2015JP011526 | NOVARTIS | 13.91 | YR | M | Y | 53.00000 | KG | 20160713 | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120889773 | 12088977 | 1 | PS | NEORAL | CYCLOSPORINE | 1 | Oral | 110 MG, BID | Y | 50715 | 110 | MG | CAPSULE | BID | |||||
| 120889773 | 12088977 | 2 | SS | NEORAL | CYCLOSPORINE | 1 | Oral | UNK (DOSE REDUCTION) | Y | 50715 | CAPSULE | ||||||||
| 120889773 | 12088977 | 3 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 120889773 | 12088977 | 4 | C | TACROLIMUS. | TACROLIMUS | 1 | Unknown | U | 0 | ||||||||||
| 120889773 | 12088977 | 5 | C | MIZORIBINE | MIZORIBINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 120889773 | 12088977 | 6 | C | AZATHIOPRINE. | AZATHIOPRINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 120889773 | 12088977 | 7 | C | RITUXAN | RITUXIMAB | 1 | Unknown | UNK | U | 0 | |||||||||
| 120889773 | 12088977 | 8 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | UNK (LOW DOSE) | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120889773 | 12088977 | 1 | Nephrotic syndrome |
| 120889773 | 12088977 | 3 | Product used for unknown indication |
| 120889773 | 12088977 | 4 | Product used for unknown indication |
| 120889773 | 12088977 | 5 | Product used for unknown indication |
| 120889773 | 12088977 | 6 | Product used for unknown indication |
| 120889773 | 12088977 | 7 | Nephrotic syndrome |
| 120889773 | 12088977 | 8 | Nephrotic syndrome |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120889773 | 12088977 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120889773 | 12088977 | Glomerulosclerosis | |
| 120889773 | 12088977 | Nephropathy | |
| 120889773 | 12088977 | Renal impairment | |
| 120889773 | 12088977 | Renal tubular atrophy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120889773 | 12088977 | 1 | 199806 | 0 | ||
| 120889773 | 12088977 | 2 | 201410 | 20150215 | 0 | |
| 120889773 | 12088977 | 3 | 199409 | 0 | ||
| 120889773 | 12088977 | 7 | 201410 | 0 |